In addition, postmortem analysis of brain tissues from AD patients shows a marked reduction in insulin‐like growth factor‐I (IGF‐I), IGF‐II, their respective receptors, and the insulin receptor at both the protein and mRNA levels (Steen et al., 2005). This evidence concerns the gene IGF1 and Alzheimer disease.